(Q37124765)

English

Blood Neutrophil-to-Lymphocyte Ratio Predicts Tumor Recurrence in Patients with Hepatocellular Carcinoma within Milan Criteria after Hepatectomy

scientific article published on September 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Blood Neutrophil-to-Lymphocyte Ratio Predicts Tumor Recurrence in Patients with Hepatocellular Carcinoma within Milan Criteria after Hepatectomy (English)

1 reference

Europe PubMed Central

18 August 2017

0 references

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Xu Guang Hu

1

1 reference

Europe PubMed Central

18 August 2017

Wei Mao

2

1 reference

Europe PubMed Central

18 August 2017

Yong Keun Park

3

1 reference

Europe PubMed Central

18 August 2017

Wei Guang Xu

4

1 reference

Europe PubMed Central

18 August 2017

Bong Wan Kim

5

1 reference

Europe PubMed Central

18 August 2017

Hee Jung Wang

6

1 reference

Europe PubMed Central

18 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2016

1 reference

Europe PubMed Central

18 August 2017

Yonsei Medical Journal

1 reference

Europe PubMed Central

18 August 2017

57

1 reference

Europe PubMed Central

18 August 2017

5

1 reference

Europe PubMed Central

18 August 2017

1115-1123

1 reference

Europe PubMed Central

18 August 2017

Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

14 September 2017

Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

14 September 2017

The linkage between inflammation and Type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

14 September 2017

Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

14 September 2017

Immunity, Inflammation, and Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

14 September 2017

Current status of liver diseases in Korea: hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

14 September 2017

Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

14 September 2017

Inflammation and cancer: back to Virchow?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

14 September 2017

Classification of chronic hepatitis: diagnosis, grading and staging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

29 September 2017

Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

27 June 2018

The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

27 June 2018

Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

27 June 2018

Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Monocyte/macrophage recruitment, activation and differentiation modulate interleukin-8 production: a paracrine role of tumor-associated macrophages in tumor angiogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4960376

3 September 2018

Does diabetes mellitus influence the perioperative outcome or long term prognosis after resection of hepatocellular carcinoma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrence of hepatocellular carcinoma after surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophil/lymphocyte ratio as a prognostic indicator of hepatic arterial infusion chemotherapy with arterial cisplatin plus continuous 5-fluorouracil

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of neutrophils by recombinant interleukin 6

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Clinical features of hepatocellular carcinoma in the 1990s]

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced hepatocellular carcinoma receiving sorafenib

1 reference

https://pubmed.ncbi.nlm.nih.gov/27401641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3349/YMJ.2016.57.5.1115

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37124765&oldid=1634220072"